Medica, one of the three largest commercial payors in Minnesota, published an exclusive, positive coverage policy for treatment of moderate to severe sacroiliac (SI) joint pain when SI-BONE’s iFuse Implant System® is used. Minimally invasive SI joint fusion will remain investigative for all other devices and procedures, and for all other indications.
Medica covers an estimated 1.1 million lives and also has enrollees in health plans throughout North Dakota, South Dakota, Kansas and Wisconsin.
“Medica’s decision to extend coverage for its members to minimally invasive SI joint fusion procedures exclusively using iFuse was supported by more than 80 peer-reviewed articles reviewing iFuse patient outcomes, including both prospective randomized trials and many independent studies,” said Jeffrey Zigler, Vice President of Market Access and Reimbursement at SI-BONE. “With the addition of Medica, there are now thirty-five U.S. commercial payers that cover SI joint fusion procedures only when iFuse is used.”
Medica, one of the three largest commercial payors in Minnesota, published an exclusive, positive coverage policy for treatment of moderate to severe sacroiliac (SI) joint pain when SI-BONE's iFuse Implant System® is used. Minimally invasive SI joint fusion will remain investigative for all other devices and procedures, and for all other...
Medica, one of the three largest commercial payors in Minnesota, published an exclusive, positive coverage policy for treatment of moderate to severe sacroiliac (SI) joint pain when SI-BONE’s iFuse Implant System® is used. Minimally invasive SI joint fusion will remain investigative for all other devices and procedures, and for all other indications.
Medica covers an estimated 1.1 million lives and also has enrollees in health plans throughout North Dakota, South Dakota, Kansas and Wisconsin.
“Medica’s decision to extend coverage for its members to minimally invasive SI joint fusion procedures exclusively using iFuse was supported by more than 80 peer-reviewed articles reviewing iFuse patient outcomes, including both prospective randomized trials and many independent studies,” said Jeffrey Zigler, Vice President of Market Access and Reimbursement at SI-BONE. “With the addition of Medica, there are now thirty-five U.S. commercial payers that cover SI joint fusion procedures only when iFuse is used.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
